Healthcare Providers and Services
Company Overview of Fox Chase Cancer Center
Fox Chase Cancer Center owns and operates a cancer care hospital in Philadelphia. It offers surgery, radiation oncology, virtual colonoscopy, diagnostic imaging, and breast imaging center of excellence seal services; and develops various therapies and technologies for treating cancer. The company also provides breast evaluation, risk assessment, and cancer education services; and conducts basic, translational, and clinical research with special programs in cancer prevention, detection, survivorship, and community outreach. In addition, it offers fellowship training in breast cancer, hematology, pathology, surgical oncology, advanced minimally invasive thoracic surgery, and urologic oncology....
333 Cottman Avenue
Philadelphia, PA 19111-2497
Founded in 1904
Key Executives for Fox Chase Cancer Center
Chief Executive Officer, President and Cancer Center Director
President of Friends of The Hospital
President of Fox Chase Chapter
Compensation as of Fiscal Year 2016.
Fox Chase Cancer Center Key Developments
Morphotek Enters into Sponsored Research Agreement with Fox Chase Cancer Center
Sep 20 16
Morphotek reported that it entered into a Sponsored Research Agreement (SRA) with Fox Chase Cancer Center (FCCC) to expand its research efforts into the immunosuppressive effects elicited by tumor shed antigens on the efficacy of immune-based therapies. The collaboration will utilize primary human organoid cultures derived from various cancer types using optimized assays developed by ongoing research in the laboratory of Dr. Wafik El-Deiry, Deputy Cancer Center Director, Translational Research Program and Co-Leader, Molecular Therapeutics Program at FCCC. The research will focus on expanding knowledge of the biological pathways involved in suppressing patients' immune responses to tumors prior to and during immune-based therapeutic exposure. These efforts aim to identify tumor molecular and cellular signatures that can aid in identifying patients who may respond to immune-based therapies, including monoclonal antibodies targeting specific tumor cell surface antigens.
Fox Chase Cancer Center Signs an Agreement with Universal Hospital in Abu Dhabi to Design Program Services for a Bone Marrow Transplant Program
Feb 19 16
Fox Chase Cancer Center signed an agreement with Universal Hospital in Abu Dhabi to design program services for a bone marrow transplant program Universal plans to establish within the United Arab Emirates. The agreement is a follow-up to a memorandum of understanding, outlining plans for the hospitals to collaborate on projects, the two organizations signed in November. As part of the partnership, Universal Hospital plans to establish exchange programs and customized physician programs at Fox Chase's affiliated hospitals in the Philadelphia region.
Fox Chase Report Earnings Results for the Year Ended June 30, 2015
Sep 25 15
Fox Chase reported earnings results for the year ended June 30, 2015. For the year, the company had an operating profit of $11.3 million in the year ended June 30 compared to an $18.5 million operating loss the year before.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|